- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Atrial Fibrillation Linked to Fourfold Rise in Cardiac Arrest Risk Among HFpEF Patients: Study Shows

USA: Atrial fibrillation (AF) substantially heightens the risk of life-threatening arrhythmias and cardiac arrest in individuals with heart failure and preserved ejection fraction (HFpEF), according to a recent study published in Heart Rhythm. The study, led by Dr. Benjamin A. Rosen and his team from Deborah Heart and Lung Center, New Jersey, highlights a pressing need to refine risk assessment strategies for this growing patient population.
Despite accounting for a considerable number of deaths among HFpEF patients, sudden cardiac death (SCD) remains poorly understood in this group, with few reliable tools for identifying high-risk individuals. The current study aimed to bridge this gap by identifying potential clinical predictors of serious ventricular arrhythmias or cardiac arrest in HFpEF patients.
Researchers conducted a retrospective cohort analysis involving 951 individuals diagnosed with HFpEF between 2015 and 2022 at a single specialized cardiac care center. Patient data—including demographics and a comprehensive set of 18 clinical variables—were extracted from electronic health records using diagnostic codes. Key variables included the presence of comorbid conditions such as coronary artery disease, hypertension, diabetes, chronic obstructive pulmonary disease, sleep apnea, anemia, chronic kidney disease, and atrial fibrillation.
The key findings were as follows:
- The average age of the study participants was 73.5 years. Women made up 52% of the total study population.
- Coronary artery disease was observed in 75% of the patients.
- Atrial fibrillation was present in 49% of the participants.
- During the study period, 5% of patients (46 individuals) experienced ventricular tachyarrhythmias or cardiac arrest.
- These events are strongly linked to a high risk of sudden cardiac death.
- Stepwise logistic regression analysis identified atrial fibrillation as a significant independent risk factor.
- Patients with atrial fibrillation had over four times higher odds of developing ventricular tachyarrhythmias or cardiac arrest (odds ratio 4.12).
These findings emphasize the crucial role that AF plays in the pathophysiology of sudden cardiac events in HFpEF patients, suggesting that AF may serve as a valuable marker in future risk stratification models.
"While HFpEF has often been considered lower risk in terms of sudden cardiac death, our data suggest that coexisting atrial fibrillation significantly alters that risk profile," the authors noted.
Given the increasing prevalence of HFpEF and the limitations in current predictive models, the authors call for further prospective research to validate these findings and develop targeted strategies for early intervention in high-risk patients.
The study contributes to the growing recognition that HFpEF, particularly when complicated by atrial fibrillation, is far from benign and demands closer clinical attention to prevent catastrophic cardiac events.
Reference:
Rosen, B. A., & Kazemian, P. (2025). Atrial fibrillation is associated with ventricular tachyarrhythmias or cardiac arrest in heart failure with preserved ejection fraction. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2025.05.050
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751